Sage Therapeutics, Inc. earnings per share and revenue

SAGE earnings per share for the last quarter are -1.56 USD whereas the estimation was -1.48 USD which accounts for -5.17% surprise. Company revenue for the same period amounts to 12.81 M USD despite the estimated figure of 14.37 M USD. Estimated earnings per share for the next quarter are -0.99 USD, and revenue is expected to reach 14.13 M USD. Also watch annual changes over time to get a bigger picture of SAGE earnings per share and revenue dynamics.